TY - JOUR
AB - Subsequently to the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 1D on p. 4392, in the 0 h row the ‘Scramble’ and ‘mimic’ panels appeared to feature overlapping data. After having re‑examined their data, the authors realize that the Figure had been assembled incorrectly, and they were able to identify the correct image for the ‘Scramble’ panel. The corrected version of Fig. 1, including the corrected data for Fig. 1D, is shown below. Note that the error made in this Figure did not affect the results or the conclusions reported in this paper, and all the authors agree to this Corrigendum. The authors thank the Editor of Oncology Letters for presenting them with the opportunity to publish this Corrigendum, and apologize to the Editor and to the readership of the Journal for any inconvenience caused. [the original article was published in Oncology Letters 15: 4390-4396, 2018; DOI: 10.3892/ol.2018.7900]
AD - Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center of Jiangxi Province, Nanchang, Jiangxi 330006, P.R. China
AU - Ye,Conglin
AU - Yu,Xiaolong
AU - Liu,Xuqiang
AU - Dai,Min
AU - Zhang,Bin
DA - 2021/02/01
DO - 10.3892/ol.2020.12394
IS - 2
JO - Oncol Lett
KW - microRNA‑30d
Ewing's sarcoma
invasion and migration
apoptosis
mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase
phosphoinositide 3‑kinase/Akt
PY - 2021
SN - 1792-1074
1792-1082
SP - 133
ST - [Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro
T2 - Oncology Letters
TI - [Corrigendum] miR-30d inhibits cell biological progression of Ewing’s sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro
UR - https://doi.org/10.3892/ol.2020.12394
VL - 21
ER -